🔥🐔 BizChicken 🐔🔥

Companies Similar to Lixte Biotechnology Holdings, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB-100 series and LB-200 series

Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.

Tags: biomarker technology, biotechnology, cancer treatment, drug discovery, enzyme targets

Symbol: LIXT

Recent Price: $2.00

Industry: Biotechnology

CEO: Mr. Bastiaan van der Baan M.Sc.

Sector: Healthcare

Employees: 3

Address: 680 East Colorado Boulevard, Pasadena, CA 91101

Phone: 631 830 7092

Last updated: 2024-12-31

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Therapeutic Candidates (INBRX-109, INBRX-106)

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.

Tags: biologic therapeutics, biopharmaceutical, cancer treatment, clinical-stage

Symbol: INBX

Recent Price: $15.14

Industry: Biotechnology

CEO: Mr. Mark Paul Lappe

Sector: Healthcare

Employees: 166

Address: 11025 North Torrey Pines Road, La Jolla, CA 92037

Phone: 858-795-4220

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo
Market Cap: Lowest
Employees: Low

TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.

Tags: CNS, autoimmunity, biopharmaceutical, cancer, immunology, infectious disease, rare disease, therapeutics

Symbol: TNXP

Recent Price: $0.36

Industry: Biotechnology

CEO: Dr. Seth Lederman M.D.

Sector: Healthcare

Employees: 103

Address: 26 Main Street, Chatham, NJ 07928

Phone: 862 799 8599

Last updated: 2024-12-31

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

BDTX-189, BDTX-1535, BDTX-4933

Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.

Tags: biotechnology, cancer treatment, genetically defined tumors, small molecule inhibitors

Symbol: BDTX

Recent Price: $2.15

Industry: Biotechnology

CEO: Dr. Mark A. Velleca M.D., Ph.D.

Sector: Healthcare

Employees: 54

Address: One Main Street, Cambridge, MA 02142

Phone: 617 252 0848

Leadership

  • Ali Behbahani, M.D., Co-Head of Healthcare, NEA
  • Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
  • Kapil Dhingra, M.D., Former Head, Roche Oncology Development
  • Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
  • Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
  • Prakash Raman, Ph.D., CEO of InduPro, Inc.
  • Mark A. Velleca, M.D., Ph.D., CEO and Board Chair

Last updated: 2024-12-31

Belite Bio, Inc

Belite Bio, Inc logo
Market Cap: High
Employees: Lowest

LBS-008

Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.

Tags: Stargardt diseases, biopharmaceutical, clinical-stage, drug development, liver disease, macular degeneration, phase 3, therapeutics

Symbol: BLTE

Recent Price: $61.97

Industry: Biotechnology

CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.

Sector: Healthcare

Employees: 20

Address: 5820 Oberlin Drive, San Diego, CA 92121

Phone: 858-246-6240

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Fortress Biotech, Inc.

Fortress Biotech, Inc. logo
Market Cap: Lowest
Employees: Low

Pharmaceutical and Biotechnology Products

Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.

Tags: Menkes disease, NSCLC, acne treatment, amyloidosis, biopharmaceutical, biotechnology, cancer treatment, dermatology, immunodeficiency, pain management, pharmaceutical, vaccines

Symbol: FBIO

Recent Price: $2.18

Industry: Biotechnology

CEO: Dr. Lindsay Allan Rosenwald

Sector: Healthcare

Employees: 186

Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154

Phone: 781 652 4500

Leadership

  • Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
  • Michael S. Weiss, Executive Vice Chairman, Strategic Development
  • David Jin, Chief Financial Officer and Head of Corporate Development
  • George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
  • Samuel Berry, General Counsel and Corporate Secretary
  • Jimmie Harvey, Jr., M.D., Director
  • Malcolm Hoenlein, Director
  • Dov Klein, Director
  • J. Jay Lobell, Director
  • Kevin L. Lorenz, J.D., Director
  • Lucy Lu, M.D., Director

Last updated: 2024-12-31

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

INT230-6

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.

Tags: biotechnology, cancer treatment, clinical trials, collaboration, solid tumors

Symbol: INTS

Recent Price: $1.82

Industry: Biotechnology

CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.

Sector: Healthcare

Employees: 5

Address: 61 Wilton Road, Westport, CT 06880

Phone: 203 221 7381

Leadership

  • Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
  • Joseph Talamo, CPA, Chief Financial Officer
  • James M. Ahlers, Executive Vice President
  • Brian Schwartz, MD, Executive VP, Clinical Development
  • John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
  • Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
  • Doranne Frano, Regulatory Affairs and Quality Control
  • Daniel J. Donovan, Board Member and Chief Executive Officer
  • Tom Dubin, Board Member
  • Mark A. Goldberg, MD, Board Member
  • Emer Leahy, Ph.D., Board Member

Last updated: 2024-12-31

Legend Biotech Corporation

Legend Biotech Corporation logo
Market Cap: Highest
Employees: High

LCAR-B38M

Legend Biotech Corporation is a clinical-stage biopharmaceutical company focusing on the discovery and development of novel cell therapies for oncology and other indications globally.

Tags: CAR-T, biopharmaceutical, cell therapy, clinical trials, lymphoma, multiple myeloma, oncology

Symbol: LEGN

Recent Price: $32.77

Industry: Biotechnology

CEO: Dr. Ying Huang Ph.D.

Sector: Healthcare

Employees: 2200

Address: 2101 Cottontail Lane, Somerset, NJ 08873

Phone: 732 317 5050

Leadership

  • Ying Huang, Ph.D., CHIEF EXECUTIVE OFFICER
  • Guowei Fang, Ph.D., CHIEF SCIENTIFIC OFFICER AND HEAD OF BUSINESS DEVELOPMENT
  • Lori Macomber, CHIEF FINANCIAL OFFICER
  • Mythili Koneru, M.D., Ph.D., CHIEF MEDICAL OFFICER
  • Jim Pepin, GENERAL COUNSEL
  • Steve Gavel, SENIOR VICE PRESIDENT, COMMERCIAL DEVELOPMENT, US & EUROPE
  • Yuhong Qiu, Ph.D., SENIOR VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS
  • Birk Vanderweeën, SENIOR VICE PRESIDENT, GLOBAL MANUFACTURING & SUPPLY
  • Alan Kick, SENIOR VICE PRESIDENT, GLOBAL QUALITY
  • Doug Wallace, VICE PRESIDENT, GLOBAL OPERATIONS
  • Elaine Qian, VICE PRESIDENT, GLOBAL HEAD OF HUMAN RESOURCES
  • Tim Roberts, Global Compliance Officer
  • Simon Wu, Senior Vice President, General Manager, Greater China
  • Frank Zhang, EMBA, Ph.D., CHAIRMAN OF THE BOARD, LEGEND BIOTECH
  • Sally Wang, M.S., PRESIDENT, GENSCRIPT
  • Zhu Li, Ph.D., CHIEF STRATEGY OFFICER, GENSCRIPT
  • Corazon (Corsee) Dating Sanders, Ph.D., CO-CHAIR OF THE BOARD OF ADVISORS, FRED HUTCH CANCER CENTER
  • Darren Ji, M.D., Ph.D. and MBA, CHAIRMAN AND CEO, ELPISCIENCE BIOPHARMACEUTICALS
  • Philip Yau, CHIEF FINANCIAL OFFICER. C&J CLARK
  • Patrick Casey, Ph.D., SENIOR VICE DEAN OF RESEARCH, DUKE-NUS MEDICAL SCHOOL SINGAPORE AND A JAMES B. DUKE PROFESSOR OF PHARMACOLOGY AND CANCER BIOLOGY, DUKE UNIVERSITY
  • Tomas J. Heyman, CEO, INTERLAKEN THERAPEUTICS
  • Li Mao, M.D., CHIEF MEDICAL OFFICER, SCICLONE PHARMACEUTICALS
  • Peter Salovey, Ph.D., Chris Argyris Professor of Psychology; Professor of Management, Epidemiology & Public Health, and Sociology; and President Emeritus of Yale University
  • Michel Vounatsos, FORMER CEO OF BIOGEN INC.
  • John Maraganore, Ph.D., FORMER CEO OF ALNYLAM PHARMACEUTICALS

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

LogicBio Therapeutics, Inc.

LogicBio Therapeutics, Inc. logo
Market Cap: Low
Employees: Medium

LB-001

Logic Bio Therapeutics, Inc. is a genetic medicine company focused on genome editing and gene therapy treatments using its Gene Ride and s AAVy platforms. Its lead product candidate, LB-001, is in clinical trials for methylmalonic acidemia.

Tags: Gene Ride, LB-001, gene therapy, genetic medicine, genome editing, methylmalonic acidemia, s AAVy

Symbol: LOGC

Recent Price: $7.08

Industry: Biotechnology

CEO: Mr. Rishi Bajaj

Sector: Healthcare

Employees: 452

Address: 65 Hayden Ave, 2Nd Floor, Lexington, MASSACHUSETTS 02421

Phone: 16172450399

Last updated: 2024-12-31

Lantern Pharma Inc.

Lantern Pharma Inc. logo
Market Cap: Lowest
Employees: Lowest

LP-100

Lantern Pharma Inc. is a clinical stage biotechnology company focused on using artificial intelligence, machine learning, and genomic data to streamline drug development, with key drug candidates including LP-100, LP-300, and LP-184 for various cancer treatments.

Tags: artificial intelligence, biotechnology, cancer treatment, drug development, genomic data, machine learning

Symbol: LTRN

Recent Price: $3.27

Industry: Biotechnology

CEO: Mr. Panna Sharma PH.D.

Sector: Healthcare

Employees: 21

Address: 1920 McKinney Avenue, Dallas, TX 75201

Phone: 972 277 1136

Last updated: 2024-12-31

Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock logo
Market Cap: Low
Employees: Low

LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004

Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.

Tags: APOE4, Batten disease, acquired diseases, cardiomyopathy, gene therapy, genetic medicine, hereditary diseases

Symbol: LXEO

Recent Price: $6.54

Industry: Biotechnology

CEO: Mr. R. Nolan Townsend

Sector: Healthcare

Employees: 69

Address: 345 Park Avenue South, New York, null 10010

Phone: 212-547-9879

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

Palisade Bio, Inc.

Palisade Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB1148

Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.

Tags: LB1148, biopharmaceutical, clinical-stage, gastrointestinal health, mucosal barrier, oral therapies

Symbol: PALI

Recent Price: $1.70

Industry: Biotechnology

CEO: Mr. J. D. Finley

Sector: Healthcare

Employees: 9

Address: 5800 Armada Drive, Carlsbad, CA 92008

Phone: 858 704 4900

Last updated: 2024-12-31

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

SON-1010, SON-080

Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.

Tags: albumin binding technology, biologic medicines, biotechnology, interleukin 12, interleukin 6, oncology

Symbol: SONN

Recent Price: $1.48

Industry: Biotechnology

CEO: Dr. Pankaj Mohan Ph.D.

Sector: Healthcare

Employees: 12

Address: 100 Overlook Center, Princeton, NJ 08540

Phone: 609-375-2227

Leadership

  • Pankaj Mohan, Ph.D., Founder, CEO & Chairman
  • Jay Cross, Chief Financial Officer
  • John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
  • Susan Dexter, Chief Technical Officer
  • Richard Kenney, M.D., Chief Medical Officer
  • Albert Dyrness, Board Member
  • Nailesh Bhatt, Chief Executive Officer & Board Member
  • Raghu Rao, Board Member
  • Donald Griffith, Financial Controller
  • Lori McNeill, Board Member

Last updated: 2024-12-31

Bio-Techne Corporation

Bio-Techne Corporation logo
Market Cap: Highest
Employees: High

Life Science Reagents, Instruments, and Services

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostics globally, operating through segments like Protein Sciences and Diagnostics and Genomics.

Tags: Diagnostics, Genomics, Instruments, Life Science, Protein Sciences, Reagents

Symbol: TECH

Recent Price: $72.29

Industry: Biotechnology

CEO: Mr. Kim Kelderman

Sector: Healthcare

Employees: 3100

Address: 614 McKinley Place N.E., Minneapolis, MN 55413

Phone: 612 379 8854

Last updated: 2024-12-31

Immix Biopharma, Inc.

Immix Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMX-110, IMX-111, IMX-120

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.

Tags: Biopharmaceuticals, Clinical Trials, Inflammation, Oncology, Tissue-Specific Therapeutics

Symbol: IMMX

Recent Price: $2.36

Industry: Biotechnology

CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.

Sector: Healthcare

Employees: 14

Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064

Phone: 310 651 8041

Last updated: 2024-12-31

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. logo
Market Cap: Highest
Employees: Medium

DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

Tags: cardiovascular, diagnostic products, healthcare, oncology, radiotherapy, therapeutic products

Symbol: LNTH

Recent Price: $89.13

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Brian A. Markison

Sector: Healthcare

Employees: 834

Address: 331 Treble Cove Road, North Billerica, MA 01862

Phone: 978 671 8001

Leadership

  • Brian Markison, Chief Executive Officer
  • Paul Blanchfield, President
  • Jeff Humphrey, MD, Chief Medical Officer
  • Robert J. Marshall Jr., Chief Financial Officer
  • Amanda Morgan, Chief Commercial Officer
  • Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
  • Jean-Claude Provost, MD, Chief Science Officer
  • Jamie Spaeth, Chief People Officer
  • Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
  • Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
  • Kim Brown, Chief Accounting Officer
  • Lee Anne Howe, Chief Information Officer
  • Linda Lennox, Chief of Staff & Vice President, Corporate Communications
  • Joann Nestor, Senior Vice President, Legal Affairs
  • Andrea Sabens, Vice President, Business Optimization
  • Carol Walker, Senior Vice President, Quality
  • Mary Anne Heino, Chairperson of the Board
  • Minnie Baylor-Henry, Director
  • Gérard Ber, PhD, Director
  • Julie Eastland, Director
  • Samuel Leno, Director
  • Heinz Mäusli, Director
  • Julie McHugh, Director
  • Gary J. Pruden, Director
  • James H. Thrall, MD, Director

Last updated: 2024-12-31